FDA Inspection 1241724 — Ana Leblanc, M.D.
The FDA completed an inspection of Ana Leblanc, M.D. on May 24, 2024 in Porto. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Porto (Portugal)
Additional details
Clinical BA/BE